27796 Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices 

Date: June 10–11, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Guangyong Ji, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3188, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1146, jig@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Virology—B Study Section. 

Date: June 10–11, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Robert Freund, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Cardiovascular and Sleep Epidemiology 

Study Section. 

Date: June 10–11, 2010. 

Time: 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: J. Scott Osborne, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4114, 

MSC 7816, Bethesda, MD 20892, (301) 435– 

1782, osbornes@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ARRA 

Revisions for SSPS. 

Date: June 10, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaylord National Hotel & 

Convention Center, 201 Waterfront Street, 

National Harbor, MD 20745. 

Contact Person: Bob Weller, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3160, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

0694, wellerr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Biological Chemistry and 

Macromolecular Biophysics. 

Date: June 10, 2010. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Donald L. Schneider, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5160, 

MSC 7842, Bethesda, MD 20892, (301) 435– 

1727, schneidd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurotechnology-3. 

Date: June 10, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington DC, 

1515 Rhode Island Avenue, NW., 

Washington, DC 20005. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Myeloid Cell Development and 

Immunoglobulin Repertoire. 

Date: June 10, 2010. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Bahiru Gametchu, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4204, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1225, gametchb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Analytical 

Chemistry Reviews. 

Date: June 10, 2010. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: John L. Bowers, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4170, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1725, bowersj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 12, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11859 Filed 5–17–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Child Health and 

Human Development Council. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: June 3, 2010. 

Open: 8 a.m. to 12:20 p.m. 

Agenda: (1) A report by the Acting 

Director, NICHD; (2) National Center for 

Medical Rehabilitation Research 

Presentation; (3) a discussion on the planning 

of the NICHD Science Vision; and other 

business of the Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C–Wing, 

Conference Room 6, Bethesda, MD 20892. 

Closed: 12:20 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C–Wing, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Yvonne T. Maddox, PhD, 

Deputy Director, National Institute of Child 

Health and Human Development, NIH, 9000 

Rockville Pike, MSC 7510, Building 31, 

Room 2A03, Bethesda, MD 20892, (301) 496– 

1848. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices 27797 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://www.

nichd.nih.gov/about/nachhd.htm, where an 

agenda and any additional information for 

the meeting will be posted when available. 

In order to facilitate public attendance at 

the open session of Council, reserve seating 

will be made available to the first five 

individuals reserving seats in the main 

meeting room, Conference Room 6. Please 

contact Ms. Lisa Kaeser, Program and Public 

Liaison Office, NICHD, at 301–496–0536 to 

make your reservation. Additional seating 

will be available in the meeting overflow 

rooms, Conference Rooms 7 and 8. 

Individuals will also be able to view the 

meeting via NIH Videocast. Please go to the 

following link for Videocast access 

instructions at: http://wwwauthor.nichd.nih.

gov/about/overview/advisory/nachhd/virtualmeeting-201005.cfm. The meeting is partially 

closed to the public. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment program, National 

Institutes of Health, HHS) 

Dated: May 12, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11848 Filed 5–17–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: June 10, 2010, 1 p.m. to 

5:30 p.m. EDT; June 11, 2010, 9 a.m. to 12:30 

p.m. EDT. 

Place: Parklawn Building (and via audio 

conference call), Conference Rooms G & H, 

5600 Fishers Lane, Rockville, MD 20857. 

The ACCV will meet on Thursday, June 10 

from 1 pm to 5:30 pm (EDT) and Friday, June 

11 from 9 a.m. to 12:30 p.m. (EDT). The 

public can join the meeting via audio 

conference call by dialing 1–888–849–8919 

on June 10 & 11 and providing the following 

information: 

Leader’s Name: Dr. Geoffrey Evans. 

Password: ACCV. 

Agenda: The agenda items for the 

December meeting will include, but are not 

limited to: updates from the Division of 

Vaccine Injury Compensation (DVIC), 

Department of Justice, National Vaccine 

Program Office, Immunization Safety Office 

(Centers for Disease Control and Prevention), 

National Institute of Allergy and Infectious 

Diseases (National Institutes of Health), and 

Center for Biologics, Evaluation and Research 

(Food and Drug Administration). Agenda 

items are subject to change as priorities 

dictate. 

Public Comments: Persons interested in 

providing an oral presentation should submit 

a written request, along with a copy of their 

presentation to: Annie Herzog, DVIC, 

Healthcare Systems Bureau (HSB), Health 

Resources and Services Administration 

(HRSA), Room 11C–26, 5600 Fishers Lane, 

Rockville, Maryland 20857 or e-mail: 

aherzog@hrsa.gov. Requests should contain 

the name, address, telephone number, and 

any business or professional affiliation of the 

person desiring to make an oral presentation. 

Groups having similar interests are requested 

to combine their comments and present them 

through a single representative. The 

allocation of time may be adjusted to 

accommodate the level of expressed interest. 

DVIC will notify each presenter by mail or 

telephone of their assigned presentation time. 

Persons who do not file an advance request 

for a presentation, but desire to make an oral 

statement, may announce it at the time of the 

comment period. These persons will be 

allocated time as it permits. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the ACCV should contact Annie Herzog, 

DVIC, HSB, HRSA, Room 11C–26, 5600 

Fishers Lane, Rockville, MD 20857; 

telephone (301) 443–6593 or e-mail: 

aherzog@hrsa.gov. 

Dated: May 11, 2010. 

Sahira Rafiullah, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–11837 Filed 5–17–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): 

Prevention of Suicidal Behavior through 

the Enhancement of Connectedness 

(U01), Request for Applications (RFA) 

CE10–006, initial review. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the aforementioned meeting: 

Times and Date: 11:30 a.m.–6:30 p.m., 

June 17, 2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Section 10(d) 

of Public Law 92–463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Prevention of Suicidal Behavior 

through the Enhancement of 

Connectedness (U01), RFA CE10–006’’. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Jane Suen, Dr.P.H., M.S., National 

Center for Injury Prevention and 

Control, Office of the Director, 

Extramural Research Program Office, 

4770 Buford Highway, NE., Mailstop F– 

63, Atlanta, Georgia 30341, Telephone 

(770) 488–4281. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: May 11, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–11887 Filed 5–17–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Meeting 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Evaluation of 

Offering and Documenting Influenza 

Vaccination for Nursing Home 

Residents, Funding Opportunity 

Announcement (FOA) IP10–001; 

Development, Implementation, and 

Evaluation of a Multi-Component 

Intervention to Vaccinate Adolescents at 

Risk for Vaccine-Preventable Diseases, 

FOA IP10–002; Evaluation and Impact 

of a State Law Requiring Mandatory 

Influenza Vaccination of Hospital 

Employees, FOA IP10–003; and 

Improving the Translation of the 

mstockstill on DSKH9S0YB1PROD with NOTICES